# Silence Therapeutics plc: Form 8-K, filed Jun 16, 2026

- Company: [Silence Therapeutics plc](/companies/sln.md) (CIK 1479615)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 17:00 ET
- Period: 2026-06-16
- Accession: 0001193125-26-272814
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479615/000119312526272814/sln-20260616.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479615/000119312526272814/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479615/000119312526272814/sln-20260616.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-272814. Last ingested by Listed: Nov 13, 2026, 02:57 ET. No prices; not investment advice.
